Helium 4He nuclei based radiotherapy
Abstract
Due to their advantageous physical and biological properties, 4He nuclei are the subject of growing interest in medicine. Low-energy 4He nuclei (α particles) are currently used in internal radiotherapy (IR) in the form of an implant in Diffusing Alpha-Emitters Radiation Therapy (DaRT) or radiopharmaceutical in Alpha - emitters based Radiopharmaceutical Therapy (αRT) and in binary therapy such as Boron Neutron Capture Therapy (BNCT) in a form of stable compound introduced into the body as a potential source of α particles in reaction with neutrons. High energy 4He ions were not used clinically since the 1990s. However, their application in external beam radiotherapy was extensively investigated and the first patient treatment was performed after a long time in 2021. The major challenging in dosimetry and treatment planning in radiation therapy with use of α particles is in vivo dose distribution monitoring in a body to get adequate information on biological response in cancerous and healthy tissues. The α particles, and in the case of BNCT also accompanying 7Li nuclei, cannot be measured directly, therefore suitable indirectly methods for imaging their distribution and concentration in tissues are emerging. Moreover, physical dose distribution imaging system shall be related to the specified biological response to allow real therapeutic effect determining and treatment plan establishment. Therefore, radiobiological parameters for weighting absorbed dose models taking into…
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.